1
H-and 13 C-NMR spectroscopy were performed with a JNM LA 400 NMR spectrometer ( 1 H, 400 MHz; 13 C, 100 MHz, JEOL Co.). HPLC was performed on a Jasco PU-980 (Tokyo, Japan) equipped with a ternary gradient unit: Jasco LG-1580-02 (Tokyo, Japan); Multiwavelength detector; Jasco MD-910 (Tokyo, Japan); Oven: Tosoh CO-8020 (Tokyo, Japan); Injector: Rhedyne 7725i (U.S.A.) under the following conditions: column, YMC-Pack ODS-A-303 (250ϫ4.6 mm I.D., 5 mm, Kyoto, Japan); mobile phase, 0.05 M AcONH 4 (pH 3.6) : CH 3 CN from 90 : 10 to 0 : 100 in 60 min; flow rate, 1.0 ml/min. Column temperature: 40°C.
Extraction of Licorice Roots and Isolation of Isoliquiritigenin Licorice, the root of Glycyrrhiza uralensis, was purchased from Tochimoto Tenkaido Co., Ltd. (Osaka, Japan). The botanical origin was confirmed by the presence of glycycoumarin , a species-specific ingredient of G. uralensis, in HPLC-profile. 7) Voucher specimens were deposited in the department of Kampo-Pharmaceutics, Institute of Natural Medicine, University of Toyama. The dried and crushed licorice (6 g for each extract) was extracted by boiling in water (600 ml) until water volume had reduced to half, filtered and freeze-dried into powder (yield about 4 g/each extract). The extract (5 g in 30 ml water) was applied to 3 showed antispasmodic activity, and these were further chromatographed on a reversephase column (diameter: 2.0 cm, length: 6.0 cm, 100C 18 , Wako Pure Chemical Industries, Ltd.) by stepwise elution with MeOH-water (50 : 50, 70 : 30, 90 : 10, 100 : 0). A part of the fractions eluted with the 50 : 50 mixture had a strong inhibitory effect. Finally, further purification of this fraction by rechromatography on the reverse-phase column led to the isolation of isoliquiritigenin (Fig. 1) 13 C-NMR (100 MHz, CD 3 OD) d: 103.9 (C-3Ј), 109.2 (C-5Ј), 114.7 (C-1Ј), 116.9 (C-3, C-5), 118.4 (C-a), 127.8 (C-1), 131.8 (C-2, C-6), 133.3 (C-6Ј), 145.6 (C-b), 161.5 (C-4), 166.5 (C-2Ј), 166.8 (C-4Ј), 193.5 (ϾCϭO). These data were in agreement with those reported. 9, 10) Treatment of an Aqueous Extract of Licorice with Naringinase An aqueous extract of licorice (55 mg of dried powder) was dissolved in 1 ml of 50 mM acetate buffer (pH 4.7), and treated with naringinase (10 mg/ml) at 37°C for 3 h. A part of the mixture was used directly for antispasmodic activity and the rest was extracted with methanol for HPLC analysis. The treatment was carried out three times for statistical analysis.
Muscle Preparation and Tension Measurement Male ICR mice (6 weeks old, 25-30 g weight) were purchased from Japan SLC Inc., (Hamamatsu, Japan) and maintained under a 12-h light-dark cycle at 21-24°C in the Laboratory for Animal Experiments, University of Toyama. The animal experiments were conducted in accordance with the guidelines for the Care and Use of Laboratory Animals at the University of Toyama. The ICR mice were maintained for one to two weeks, then starved overnight with free access to water before the experiments, and killed by exsanguination. The jejunum, ileum and rectum were excised rapidly, cleaned of connective tissues, and cut into rings of 10-15 mm in length. The rings were maintained in Tyrode solution. The muscle tension was recorded isometrically as described previously.
6)
Assay of cAMP or cGMP Content cAMP or cGMP content was measured by enzyme immunoassay as reported previously.
Data Analysis The concentrations of drugs were expressed as final concentrations in the organ bath. Data are expressed as the mean valuesϮstandard deviation of the mean (S.D.). Statistical analysis was performed using paired and unpaired two-tailed Student's t test. Differences at pϽ0.05 were accepted as statistically significant.
RESULTS

Effects of Isoliquiritigenin on Contractile Responses in Mouse Jejunum
Bio-assay-guided fractionation and purification of the aqueous extract of licorice led to the isolation of isoliquiritigenin ( Fig. 1) as a potent spasmolytic. Isoliquiritigenin showed concentration-dependent inhibition of the tonic contraction of mouse jejunum induced by various types of stimulants such as CCh (1 mM), KCl (60 mM) and BaCl 2 (0.3 mM) ( Fig. 2) with IC 50 values of 4.96Ϯ1.97 mM, 4.03Ϯ1.34 mM and 3.70Ϯ0.58 mM, respectively, which were close to those (1.64Ϯ0.46 mM, 0.78Ϯ0.51 mM and 2.35Ϯ 0.16 mM for CCh-, KCl-and BaCl 2 -induced contraction, respectively) for papaverine. Moreover, pretreatment with isoliquiritigenin inhibited non-competitively the contraction caused by the cumulative addition of ACh as strongly as papaverine, while the inhibitory effect of butylscopolammonium bromide was competitive (Fig. 3) . These results indicate that isoliquiritigenin has potent relaxant effects against the actions of various stimulants similar to those of papaverine, and that the mechanism responsible may be similar to that of papaverine.
Little Relationship between Relaxation Action and 
PDE-inhibitory Effect of Isoliquiritigenin
As papaverine relaxes smooth muscle through inhibition of PDEs 11, 12) and isoliquiritigenin is a potent inhibitor of PDEs, 13) we studied the relationship between the antispasmodic action of isoliquiritigenin and its PDE inhibition. The adenylyl cyclase activator, forskolin, inhibited the CCh-induced contraction of mouse jejunum in a concentration-dependent manner (IC 50 ϭ0.25Ϯ0.08 mM). As shown in Fig. 4 , the inhibition was not significantly accelerated by pretreatment with isoliquiritigenin (10 mM) in spite of a shift in the IC 50 to 0.16Ϯ0.08 mM, whereas it was increased significantly by IBMX (10 mM), a potent non-selective inhibitor of PDEs, and glycycoumarin (10 mM), a PDE 3 inhibitor from licorice, with IC 50 values of 0.06Ϯ0.02 mM and 0.11Ϯ0.04 mM, respectively. On the other hand, the inhibition of CCh-induced contraction with IBMX (IC 50 ϭ3.23Ϯ0.72 mM) tended to be decreased by pretreatment of isoliquiritigenin (1 mM), shifting the IC 50 to 3.85Ϯ0.08 mM (data not shown), whereas it was increased significantly by pretreatment with glycycoumarin (1 mM), shifting the IC 50 to 1.44Ϯ0.35 mM. Moreover, isoliquiritigenin did not increase the content of cAMP or cGMP in mouse jejunum (data not shown). These results suggest that the relaxant action of isoliquiritigenin on the mouse jejunum might be not related to its PDE inhibition.
Effects of Related Constituents in Licorice on Contractile Responses in Mouse Jejunum
Although isoliquiritigenin showed potent concentration-dependent inhibition of CCh-induced contraction of mouse jejunum, the effect of liquiritigenin (a major flavanone of licorice, Fig. 1 ) was considerably weak. Glycosides such as liquiritin, liquiritin apioside and isoliquiritin (major constituents of licorice, Fig. 1 ) were inactive. However, davidigenin, a metabolite of liquiritigenin 14) having a chalcone structure like that of isoliquiritigenin, showed potent inhibition with an IC 50 value of 5.07Ϯ1.63 mM (Fig. 5) .
Enhancement of the Relaxant Action of Licorice Extract by Naringinase HPLC analysis of the aqueous extract of licorice did not show any peak of isoliquiritigenin, suggesting only a trace amount of this compound in the extract (Fig. 6) , though its glycosides, isoliquiritin and isoliquiritin apioside, were present abundantly. 15) When the aqueous extract of licorice was treated with naringinase, the amounts of glycosides such as liquiritin and isoliquiritin were decreased, while those of their aglycones such as liquiritigenin and isoliquiritigenin were increased (Fig. 6) . Furthermore, the inhibition of CCh-induced contraction of mouse jejunum with the aqueous extract of licorice was significantly increased by treatment with naringinase, shifting the IC 50 from 358Ϯ104 to 150Ϯ38 mg/ml (Fig. 7) . In addition to the effect on the jejunum, isoliquiritigenin also inhibited CCh-induced contraction of the mouse ileum and rectum ( Fig. 8) with IC 50 values of 5.55Ϯ2.79 mM and 1.70Ϯ0.07 mM, respectively, showing the strongest effect on the rectum.
DISCUSSION
Shakuyakukanzoto (Shaoyao-Gancao-tang), an aqueous extract of a mixture of Paeoniae Radix and Glycyrrhizae Radix (licorice), is prescribed for abdominal pain in Japan. Shakuyakukanzoto and Kanzoto (an aqueous extract of licorice), but not an aqueous extract of Paeoniae Radix, have been reported to inhibit the contraction induced by ACh in guinea pig ileum 2) and in mouse jejunum and ileum. 6) Recently, glycycoumarin has been isolated from the aqueous extract of licorice and shown to have an IC 50 value of 2.93Ϯ0.94 mM for inhibition of CCh-induced contraction, the potency being similar to that of papaverine. However, the content of glycycoumarin in the extract was only 0.1%, suggesting the presence of other relaxant constituents.
In the present study, isoliquiritigenin was also isolated from an aqueous extract of licorice as a potent antispasmodic with an IC 50 value of 4.96Ϯ1.97 mM, in addition to glycycoumarin. Isoliquiritigenin inhibited the contraction induced by various types of stimulants (Fig. 2) at the mM order of concentration with almost the same potency as glycycoumarin and papaverine. It is generally accepted that the action of papaverine is related to accumulation of intracellular cAMP through inhibition of PDEs. 11, 12) We have also reported that glycycoumarin exerts a relaxant effect by accumulation of intracellular cAMP through inhibition of PDE3.
6) However, pretreatment with isoliquiritigenin did not enhance significantly the inhibition of CCh-evoked contraction in mouse jejunum by forskolin, an adenylyl cyclase activator, in spite of significant enhancement by pretreatment with IBMX, a potent non-specific inhibitor of PDEs, and glycycoumarin (Fig.  3) . Moreover, isoliquiritigenin increased neither the content of cAMP nor cGMP in mouse jejunum (data not shown), wheraeas glycycoumarin increased the content of cAMP 6) to an extent almost equivalent to that obtained with papaverine in guinea pig ileum. 16) Although isoliquiritigenin and glycycoumarin are potent inhibitors of PDEs, 13) the former (IC 50 180 mM) is much weaker, by two orders of magnitude, than the latter (IC 50 7 mM). Accordingly, the relaxant effect of isoliquiritigenin seemed to have no relationship to its weak PDE inhibition.
The content of isoliquiritigenin in the aqueous extract of liquorice is trace (Fig. 6 ), but its glycosides such as isoliquiritin and isoliquiritin apioside are present in abundance, 15) although they showed no relaxant effect (Fig. 5) . When Shakuyakukanzoto is administered orally, the glycosides are not absorbed and carried into the lower part of the intestine, where intestinal bacteria producing b-D-glucosidases are present. 17) There, isoliquiritigenin is produced from its glycosides, supported by isoliquiritigenin production from isoliquiritin with naringinase (b-D-glucosidase) (Fig. 6) . The inhibitory effect of the aqueous extract of licorice on CChinduced contraction was significantly increased after treatment with naringinase ( Fig. 7) , shifting the IC 50 from 358 mg/ml to 150 mg/ml. As the content of isoliquiritigenin in the aqueous extract of licorice after treatment with naringinase was 0.246% (w/w), as determined by HPLC, isoliquiritigenin at 208 mg/ml obtained by subtraction of the two IC 50 values was assumed to be about 2 mM. This concentration was close to the IC 50 of isoliquiritigenin, suggesting that enhancement of the inhibitory effect by treatment with naringinase was caused mainly by isoliquiritigenin produced. Furthermore, among the various parts of the intestine isoliquiritigenin exerted the most potent inhibition against rectal contraction (Fig. 8) , suggesting that isoliquiritigenin is one of the genuine principles of Shakuyakukanzoto that relieves pain in the lower intestine. In fact, the aqueous extract of licorice exerts a relaxant effect on contraction in the lower part of the rat intestine induced by Rhei Rhizoma. 18) On the other hand, the antispasmodic effect of liquiritigenin, another of the major flavonoids in liquorice, was much weaker than that of isoliquiritigenin (Fig. 5) . However, davidigenin, which is not found in licorice root but is transformed from liquiritigenin by human intestinal flora, 14) inhibited the CCh-evoked contraction ( Fig. 5) with almost the same potency as isoliquiritigenin. As davidigenin also has a chalcone structure in its fundamental skeleton, similar to that of isoliquiritigenin, whereas liquiritigenin does not, the chalcone structure may be important for the relaxant effect.
In conclusion, this study has clarified for the first time that isoliquiritigenin acts as a potent antispasmodic agent on mouse intestine, especially the lower intestine by transformation from its glycosides. 
